EUVIMEDEUVIMED entdecken
Crossref

Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis

Fan Cao, Kun Liang, Wei-Wei Tang, Qin-Yu Ni, Zhi-Yu Ji, Chen-Kai Zha, Ya-Kun Wang, Zheng-Xuan Jiang, Shengping Hou, Li-Ming Tao, Xianwen Wang

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.06.047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Fan Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, PR China; Department of Clinical Medicine, The…. Hauptthemen laut MEDLINE: Curcumin, Uveitis, Povidone, Nanoparticles. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Key Scientific Research Project of Colleges and Universities in Henan Province, Anhui Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uveitis comprises a cluster of intraocular inflammatory disorders characterized by uncontrolled autoimmune responses and excessive oxidative stress leading to vision loss worldwide. In the present study, curcumin (CUR) was conjugated with polyvinylpyrrolidone (PVP) to form PVP-CUR nanoparticles with significantly elevated solubility and outstanding multiple radical scavenging abilities. In vitro studies revealed that PVP-CUR nanoparticles markedly mitigated oxidative stress and reduced apoptosis in a H2O2-induced human retinal pigment epithelial cell line (ARPE-19) and promoted phenotypic polarization from M1 to M2 in an LPS-induced human microglial cell line (HMC3). Further in vivo studies demonstrated the prominent therapeutic effects of PVP-CUR nanoparticles on experimental autoimmune uveitis (EAU), which relieved clinical and pathological progression, improved perfusion and tomographic manifestations of retinal vessels, and reduced blood-retinal barrier (BRB) leakage; these effects may be mediated by mitigating oxidative stress and attenuating macrophage/microglia-elicited inflammation. Notably, treatment with PVP-CUR nanoparticles was shown to regulate metabolite alterations in EAU rats, providing novel insights into the underlying mechanisms involved. Additionally, the PVP-CUR nanoparticles showed great biocompatibility in vivo. In summary, our study revealed that PVP-CUR nanoparticles may serve as effective and safe nanodrugs for treating uveitis and other oxidative stress- and inflammation-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminUveitisPovidoneNanoparticlesAutoimmune DiseasesOxidative StressAnimalsHumansCell LineRetinal Pigment EpitheliumRatsFemaleRats, Inbred LewBlood-Retinal BarrierMale

Stichwörter der Autor:innen

CurcuminEAUExperimental autoimmune uveitisInflammationNanoparticlesPolyvinylpyrrolidone

Substanzen

CurcuminPovidone

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, PR China; Department of Clinical Medicine, The Second School of Clinical Medicine, Anhui Medical University, Hefei 2…
  • Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, PR China.
  • Department of Clinical Medicine, The Second School of Clinical Medicine, Anhui Medical University, Hefei 230032, PR China.
  • Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
  • Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, PR China. Electronic address: jiangzhengxuan@ahmu.edu.cn.
  • Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, PR China. Electronic address: sphou828@163.com.

Förderung

  • Key Scientific Research Project of Colleges and Universities in Henan Province
  • Anhui Medical University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Cao, F., Liang, K., Tang, W. W., Ni, Q. Y., Ji, Z. Y., Zha, C. K., Wang, Y. K., Jiang, Z. X., Hou, S., Tao, L. M., & Wang, X. (2024). Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.06.047

Vancouver

Cao F, Liang K, Tang WW, Ni QY, Ji ZY, Zha CK, et al. Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.06.047

BibTeX
@article{Cao2024,
  author = {Cao, Fan and Liang, Kun and Tang, Wei-Wei and Ni, Qin-Yu and Ji, Zhi-Yu and Zha, Chen-Kai and Wang, Ya-Kun and Jiang, Zheng-Xuan and Hou, Shengping and Tao, Li-Ming and Wang, Xianwen},
  title = {Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.06.047}
}
Kostenlos starten →